All In MedTech

FDA Clearance Tracker · P980022-S023

MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 17, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 17, 2008

Approved

Time to decision

216 days

Received Dec 14, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980022-S023
Device name
MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEM
Applicant location
Northridge, CA
Received
Dec 14, 2007
Decided
Jul 17, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P980022

Device type

Device class
Class III

Every decision under product code MDS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN UPDATE OF SOFTWARE USED IN MODEL MMT 512 AND MMT 712 INSULIN PUMPS TO VERSION 2.2A.

Source documents

Other decisions for Medtronic Minimed

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.